Furthermore, recent work identified KPNA2 as a potential prognostic marker for the progression of prostate cancer [36], non-muscle-invasive bladder cancer [37], as well as non-small cell lung cancer [38], hepatocellular carcinoma. Here, KPNA2 is linked to prostate cancer.